Partner Series—Joint Health in Record Time

Available: On Demand
Posted in Webinar, Bone/Joint Health

Speakers: Chris Haynes, Director of Sales, ESM Technologies; Joe Evans, Ph.D., Manager of Pharmacology, Stratum Nutrition

Watch Now

INSIDER Partner Series

 

Arthritis and related rheumatic conditions are one of the most common chronic health problems, affecting 1 in 5 Americans and limiting the daily activities of 19 million adults due to related pain and stiffness in joints. While nutraceutical ingredients offer many benefits over time, many consumers are looking for fast relief from pain along with long-term bone and joint support. To fill this need, ESM Technologies developed NEM® (Natural Eggshell Membrane) and ESC® (Eggshell Calcium), two novel renewable source ingredients. Three recently published clinical trials concluded NEM® can significantly reduce joint pain and stiffness in as little as 10 days. Scientific studies have also found ESC, a pure source of calcium with no harsh side effects, can actually build bone density.

 

Speakers:

 

Chris Haynes, Director of Sales for ESM Technologies, has been a part of the natural product industry for nearly 20 years.  Working with a variety of ingredient types, he has helped concept and develop innovative products for companies throughout the industry.  Chris has a vast understanding of the changes within the natural products industry and how new products can fit into the marketplace.

Joe Evans, Ph.D., Manager of Pharmacology for Stratum Nutrition, holds a Ph.D. in biochemistry from Drexel University, Philadelphia, Pa., and post-doctoral training in Molecular biology, pharmacology and physiology at Dartmouth Medical School and The University of Copenhagen. Evans has more than 20 years of experience in the pharmaceutical, biotechnology, and dietary supplement industries, and has co-founded or helped launch five different biotech and nutritional start-up companies. His research interests focus on identifying and commercializing pharmaceutical and natural product interventions for the metabolic and inflammatory diseases. Evans has published more than 40 original research papers, reviews and patents, and has served as a reviewer for more than 30 different scientific journals.

 

 

 

Content developed and sponsored by

ESM Technologies 

Related Materials

Please log in to access the related material